About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Investor presentation - Antisense Therapeutics Limited
Antisense Therapeutics Limited
Health
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Read moreMarket Cap
$120.55m
Price at Close
$0.21
4w avg. Volume
5.52m
4w avg. Turnover
$1.08m
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| +19.05% | 15 Jan 2021 |
| +19.05% | 15 Jan 2021 |
| +18.92% | 14 Jan 2021 |
| +11.11% | 11 Jan 2021 |
| 0.00% | 18 Dec 2020 |
| -13.33% | 17 Dec 2020 |
| -13.33% | 17 Dec 2020 |
| +19.57% | 13 Dec 2020 |
| -4.00% | 07 Dec 2020 |
| 0.00% | 03 Dec 2020 |
Market Data
Current Price
$0.21
52WK HIGH
$0.27
52WK LOW
$0.029
1YR RETURN
+176.32%
1YR RETURN VS. SECTOR
+137.63%
90 DAY RETURN
+68.00%
ASX RANK
811
/2,048
SECTOR RANK
70
/168
SHARES OUTSTANDING
574.06m
Antisense Therapeutics Limited
Health
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Read moreMarket Cap
$120.55m
Price at Close
$0.21
4w avg. Volume
5.52m
4w avg. Turnover
$1.08m
ASX:ANP is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia